欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Hukyndra	Human	adalimumab	adalimumab	EMEA/H/C/005548	Stada Arzneimittel AG	2021/11/15	Authorised
Libmyris	Human	adalimumab	adalimumab	EMEA/H/C/005947	Stada Arzneimittel AG	2021/11/12	Authorised
Yuflyma	Human	adalimumab	adalimumab	EMEA/H/C/005188	Celltrion Healthcare Hungary Kft.	2021/02/11	Authorised
Amsparity	Human	adalimumab	adalimumab	EMEA/H/C/004879	Pfizer Europe MA EEIG	2020/02/13	Authorised
Idacio	Human	adalimumab	adalimumab	EMEA/H/C/004475	Fresenius Kabi Deutschland GmbH	2019/04/02	Authorised
Kromeya	Human	adalimumab	adalimumab	EMEA/H/C/005158	Fresenius Kabi Deutschland GmbH	2019/04/02	Withdrawn
Hulio	Human	adalimumab	adalimumab	EMEA/H/C/004429	Biosimilar Collaborations Ireland Limited	2018/09/17	Authorised
Hyrimoz	Human	adalimumab	adalimumab	EMEA/H/C/004320	Sandoz GmbH	2018/07/26	Authorised
Hefiya	Human	adalimumab	adalimumab	EMEA/H/C/004865	Sandoz GmbH	2018/07/26	Authorised
Halimatoz	Human	adalimumab	adalimumab	EMEA/H/C/004866	Sandoz GmbH	2018/07/26	Withdrawn
Cyltezo	Human	adalimumab	adalimumab	EMEA/H/C/004319	Boehringer Ingelheim International GmbH	2017/11/10	Withdrawn
Imraldi	Human	adalimumab	adalimumab	EMEA/H/C/004279	Samsung Bioepis NL B.V.	2017/08/24	Authorised
Solymbic	Human	adalimumab	adalimumab	EMEA/H/C/004373	Amgen Europe B.V.	2017/03/22	Withdrawn
Amgevita	Human	adalimumab	adalimumab	EMEA/H/C/004212	Amgen Europe B.V.	2017/03/21	Authorised
Humira	Human	adalimumab	adalimumab	EMEA/H/C/000481	AbbVie Deutschland GmbH & Co. KG	2003/09/08	Authorised
Trudexa	Human	adalimumab	adalimumab	EMEA/H/C/000482	Abbott Laboratories Ltd.	2003/09/01	Withdrawn
Fyzoclad	Human	adalimumab	adalimumab	EMEA/H/C/005253	Pfizer Europe MA EEIG		Application withdrawn

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-